PE102699A1 - Combinacion de antiacido y papaina - Google Patents

Combinacion de antiacido y papaina

Info

Publication number
PE102699A1
PE102699A1 PE1998000622A PE00062298A PE102699A1 PE 102699 A1 PE102699 A1 PE 102699A1 PE 1998000622 A PE1998000622 A PE 1998000622A PE 00062298 A PE00062298 A PE 00062298A PE 102699 A1 PE102699 A1 PE 102699A1
Authority
PE
Peru
Prior art keywords
compositions
acidity
reduce
papaya
ingredients
Prior art date
Application number
PE1998000622A
Other languages
English (en)
Inventor
Constantine Georgiades
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PE102699A1 publication Critical patent/PE102699A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22002—Papain (3.4.22.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

QUE COMPRENDE: A) UNA O MAS COMPOSICIONES QUE REDUCEN LA ACIDEZ GASTRICA, QUE SE ELIGEN DE ENTRE: COMPOSICIONES QUE REDUCEN LA CONCENTRACION INTRAGASTRICA DEL HIDROGENION MEDIANTE LA NEUTRALIZACION QUIMICA, ANTAGONISTAS DEL RECEPTOR H2, COMPUESTOS DE BISMUTO, ENTRE OTROS; Y B) UNA COMPOSICION EXTRAIDA DE LA PAPAYA, QUE COMPRENDE PREFERENTEMENTE UNA O MAS ENZIMAS PROTEOLITICAS TALES COMO PAPAINA, QUIMOPAPAINA Y PROTEINASA III DE PAPAYA. SE REFIERE TAMBIEN A UN METODO PARA PREPARAR LA COMPOSICION ANTERIORMENTE DESCRITA, QUE COMPRENDE: 1) MEZCLAR UNO O MAS COMPOSICIONES QUE REDUCEN LA ACIDEZ GASTRICA QUE SE ENCUENTRAN EN FORMA SECA, EXTRACTO DE PAPAYA SECA Y DEMAS INGREDIENTES SECOS ELEGIDOS DEL GRUPO FORMADO POR EXCIPIENTES, LIGANTES, ALMIDONES, Y AZUCARES; 2) MEZCLAR MINUCIOSAMENTE LOS INGREDIENTES DEL PASO (1); Y 3) PREPARAR LOS INGREDIENTES DEL PASO (2) EN LA FORMA DE POLVO; Y ADICIONALMENTE COMPRENDE EL PASO DE COMPRIMIR DICHO POLVO PARA FORMAR UNA PASTILLA O COMPRIMIDO. LA PRESENTE COMPOSICION QUE ALIVIA EL MALESTAR ESTOMACAL TIENE USO EN EL TRATAMIENTO DE SINTOMAS DE SECRESION EXCESIVA DE ACIDO GASTRICO, TAL COMO ACIDEZ, DOLOR DE ESTOMAGO Y SIMILARES
PE1998000622A 1997-07-15 1998-07-15 Combinacion de antiacido y papaina PE102699A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5254397P 1997-07-15 1997-07-15

Publications (1)

Publication Number Publication Date
PE102699A1 true PE102699A1 (es) 1999-11-05

Family

ID=21978305

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000622A PE102699A1 (es) 1997-07-15 1998-07-15 Combinacion de antiacido y papaina

Country Status (9)

Country Link
EP (1) EP1001796A1 (es)
JP (1) JP2002509539A (es)
AR (1) AR016514A1 (es)
AU (1) AU8296898A (es)
BR (1) BR9809419A (es)
CA (1) CA2286357A1 (es)
PE (1) PE102699A1 (es)
WO (1) WO1999003486A1 (es)
ZA (1) ZA986247B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000083619A (ja) * 1998-07-15 2000-03-28 Oju Seiyaku:Kk 健康食品とその製造方法
BRPI0006503B1 (pt) * 2000-02-04 2017-05-09 Biolab Sanus Farmacêutica Ltda composição em forma de gel, creme, aerosol, spray, líquida e liofilizada de substância carreadora de produtos à base de papaína
WO2007010547A1 (en) * 2004-11-04 2007-01-25 Abhoy Sankar Arora A phyto-medicine and a process for the preparation thereof
GB0820846D0 (en) * 2008-11-14 2008-12-24 Carson John W Improved proteinaceous digestates
IT201700090582A1 (it) * 2017-08-04 2019-02-04 Neilos S R L Composizione per l’uso nella prevenzione e/o nel trattamento di disturbi gastrici o gastroesofagei.

Also Published As

Publication number Publication date
ZA986247B (en) 1999-02-05
WO1999003486A1 (en) 1999-01-28
AU8296898A (en) 1999-02-10
JP2002509539A (ja) 2002-03-26
AR016514A1 (es) 2001-07-25
BR9809419A (pt) 2000-06-13
CA2286357A1 (en) 1999-01-28
EP1001796A1 (en) 2000-05-24

Similar Documents

Publication Publication Date Title
TR200101347T2 (tr) Oral kalsiyum kompozisyonlarının hazırlama işlemi.
IL154988A0 (en) Pharmaceutical compositions containing a 5-ht3 receptor antagonist
NO20034230L (no) 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
UY25611A1 (es) Formas solidas de dosificacion oral para el tratamiento de diabetes no dependiente de insulina
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
MXPA05010137A (es) Derivados de tetrahidroisoquinolil acetamida para usarse como antagonistas del receptor de orexina.
NZ520624A (en) 1,2,3,4-tetrahydroisoquinoline derivatives
IL162851A0 (en) 4-(Piperidyl-and pyrrolidyl-alkyl-ureido)-quinolines as urotensin ii receptor antagonists
US1716035A (en) Tooth paste
PE102699A1 (es) Combinacion de antiacido y papaina
IT1170215B (it) Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
ES8605956A1 (es) Procedimiento para preparar una composicion antiacido
ES269650A1 (es) Procedimiento para la fabricaciën de comprimidos
BR9909637A (pt) Processo para a produção de um tablete de uma composição particulada compactada, tablete de composição particulada compactada, e, usos de cristais ou acetato de sódio hidratado ou anidro, acetato de potássio ou misturas dos mesmos e de cristais ou triidrato de acetato de sódio hidratado ou anidro, acetato de potássio ou mistura dos mesmos
MXPA04001252A (es) Nuevos heterociclos benzo-fusionados como antagonistas de endotelina.
PE20000644A1 (es) Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratiroidea
MXPA03000430A (es) Nuevas arileteno-sulfonamidas.
KR101869976B1 (ko) 흔들어서 사용되는 팩용 화장료 조성물
JP2010120909A (ja) 外用塗布剤、外用塗布クリーム及び外用塗布ジェル
GB895398A (en) Improvements in and relating to plaster compositions
CO5231214A1 (es) Un proceso de preparacion de una composicion detergente en barra
MXPA02006250A (es) Derivados de butino diol.
JPS62119149A (ja) 活性化アツシユセメント及びその製法
GB2020687A (en) Washing powder
JP2938355B2 (ja) 丸 薬

Legal Events

Date Code Title Description
FD Application declared void or lapsed